Research tool page — not in the public editorial index
This company can still be explored inside Wall Street Score, but this URL remains noindex and is not eligible for Google-served ads until source-specific publisher curation is documented and the public research-quality checks pass.
Rafael Holdings, Inc.
RFL · Price history
Price at last available close
$1.12
−$0.20 (-15.15%) 1M
2026-10-29
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Company & revenue
About Rafael Holdings, Inc.
Primary reporting period: 2025-07-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
Rafael Holdings, Inc. holds strategic investments in both early-stage and clinical pharmaceutical companies, alongside a portfolio of commercial real estate assets situated in the United States and Israel. The company's business activities are structured into two primary divisions: Pharmaceuticals and Real Estate. Its Real Estate segment manages and leases a commercial office complex, which features an integrated 800-space public parking facility.
How they make money
Rafael Holdings, Inc. is a biotechnology company that develops pharmaceuticals and holds interests in clinical and early-stage companies that develop pharmaceuticals and medical devices. The company focuses on advancing its lead candidate, Trappsol Cyclo, for Niemann-Pick Disease Type C1, while managing a portfolio of majority-owned subsidiaries in the cancer metabolism and orthopedic medical device sectors.
Products & services
Pharmaceutical development, specifically Trappsol Cyclo for Niemann-Pick Disease Type C1; cancer metabolism-based therapeutics; and orthopedic medical devices for minimally invasive surgeries.
Brands & revenue mix
Lead pharmaceutical candidate being evaluated for the treatment of Niemann-Pick Disease Type C1.
Separate brand revenue is not available in this research.Source
Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.
Product / operating segments
No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
Customer types
- Clinical trial participants and healthcare providersSource
Customer concentration
No quantified customer-concentration disclosure is available in the current saved research.
Suppliers, materials & equipment
No supplier relationships were confirmed in the sources reviewed. This does not mean the company has no suppliers.
Strengths
- Portfolio of clinical and early-stage pharmaceutical and medical device assetsSource
Sources
Financial risk observations and what to check
These are saved observations about business performance, not predictions. Review the company filings alongside the interpretation below. Latest stored financial period end: 2026-04-30.
Opportunity Score is currently unavailable; Wall Street Score remains independently validated.
The unavailable Opportunity Score is a separate model output. It must not be substituted with zero or inferred from the company score.
Quarterly revenue fell 50.6% versus the same quarter last year.
Check comparable business scope and currency, then separate volume, pricing and divestitures. One weaker quarter does not establish that the same decline will continue.
Diluted weighted-average shares increased 103.0% year over year.
Compare per-share results with total earnings and inspect the equity footnote. A change in weighted-average shares does not by itself establish the cause, the number of shares issued today, or the economic effect of a split.
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
22
Poor
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
23
Poor
Financial Strength
7
Business Quality / Moat
20
Management
40
Growth Quality
52
Risk / Durability
0
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Model Outlook
12-month model · What does the model think happens next?
Outperformance analysis is not currently available.
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
A current Opportunity Score is not available.
The 12-month model outlook is not currently available.
- •Asset quality scores strongly
- •Debt service risk
- •Valuation is a weaker part of the current profile
- •Revenue fundamentals are weak
- •Debt / balance-sheet profile needs attention
Company-specific research
Questions worth answering for RFL
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •Can RFL maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
- •How long can RFL fund negative free cash flow using its current cash position before it may need more debt or new shares?
- •How is RFL likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
- •What specifically needs to improve for RFL to reach sustainable profitability?
- •What future growth or profitability would be needed to justify RFL's current valuation?
Essential Investment Snapshot
Wall Street Score
22
Market Cap
$57.4M
P/E Ratio
-2.1
EPS
$-0.68
52-Week High
$3.96
52-Week Low
$1.12
Beta
0.35
Shares Outstanding
29.4M
Total Revenue
$980K
Total Debt
$610K
Dividend
No current dividend
Liquidation Value / Share
$2.75
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Strong downward momentum
Elevated movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for RFL
Detected from reported data — verify before acting.Debt service risk
Interest coverage is low (~-39.7x). Earnings may be strained to cover interest expense.
Community Sentiment
0 active · 0 total callsNo personal call yet on RFL.
Potential upside factors
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Portfolio of clinical and early-stage pharmaceutical and medical device assets.
Potential downside factors
- −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Real Estate - Services industry.
- −History of operating losses and dependence on additional capital to fund operations.
- −Risks associated with clinical trial success, regulatory approval, and commercialization of pharmaceutical products.
- −Diluted weighted-average shares increased 103.0% year over year.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
3 historical score records availablePrevious Score
22
Oct 1, 2026
Change
Unchanged
Current Score
22
Oct 15, 2026
Category Changes
RFL score was unchanged.
Projected Score
Projected Score
14
Projected Change
-7.6 points
Preliminary comparable-period financial changes suggest decline of approximately 7.6 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
Valuation unavailableCurrent Price
$1.12
Model Intrinsic Value
—
Difference
—
Margin of Safety
—
Intrinsic value is not currently available for this stock, so valuation can't be calculated.
Financial Charts
Revenue
Additional Metrics
Operating Cash Flow
Total Debt
Total Assets
Net Margin %
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
| Line Item | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $980K | $917K | $637K | $279K | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Cost of Revenue | $153K | $422K | $154K | $0.00 | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Gross Profit | $827K | $495K | $483K | $279K | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Research & Development | $24.4M | $12.8M | $94.0M | $6.3M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| SG&A Expenses | $12.7M | $13.8M | $8.9M | $8.9M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Operating Expenses | $37.3M | $26.6M | $103.1M | $15.3M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| EBITDA | -$31.0M | -$32.3M | -$66.8M | -$8.7M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Operating Income | -$36.4M | -$26.1M | -$102.6M | -$15.0M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Interest Expense | $495K | $658K | $248K | $0.00 | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Income Before Tax | -$31.2M | -$33.2M | -$67.7M | -$8.9M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Income Tax Expense | -$110K | -$2.6M | -$2.7M | -$255K | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Net Income | -$32.6M | -$30.5M | -$34.4M | -$1.9M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Basic EPS | $-0.68 | $-1.04 | $-1.45 | $-0.08 | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Basic Shares | 51.23M | 29.42M | 23.75M | 23.26M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Diluted Shares | 51.23M | 29.42M | 23.75M | 23.26M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
Earnings Summary
Revenue
$179000
Estimate unavailable.
Revenue Beat/Miss
Not available (no estimate stored)
EPS
-$0.08
Estimate unavailable.
EPS Beat/Miss
Not available (no estimate stored)
Debt Change
-11.6%
Cash Change
-19.6%
Margin Change
-1040.7 pp
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
- Debt reduced
What Weakened
- Margins contracted
- Cash position declined
Potential Score Impact
Positive indicators included debt levels. Pressure indicators included revenue growth, EPS growth, cash levels, net income margin. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue declined 50.6%. EPS declined 56.6%. Cash declined 19.6%. Total debt declined 11.6%. Net income margin declined by 1040.7 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Insider Activity
Guru / Smart Money
Guru Score
Smart Money
Number of Gurus
Total Guru Value
Avg Portfolio Weight
Largest Holder
Largest Holder %
New Positions
Increased Positions
Reduced Positions
Exited Positions
Net Guru Sentiment
Short Interest
Dividend History
Dividend data is not available yet. Missing data does not mean this company pays no dividend.
Conservative Projected Values
3 Years
$———.——
5 Years
$———.——
10 Years
$———.——
Conservative Projection Rate
——%
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Start 7-Day Free TrialHistorical Outperformance Record
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.
Start 7-Day Free TrialHistorical Trends
3 historical recordsHistorical Score Chart
3 of 3 records shownWall Street Score
Debt Score
Revenue Score
Asset Score
Capital Score
Management Score
Moat Score
Valuation Score
Buffett Score
Intrinsic Value
Value Reference
Margin of Safety %
Related Companies
Real Estate - ServicesNews
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL
Rumor Mill · RFL
Corporate developments & opportunities
No reviewed developments match this filter.
The reliability percentage measures the strength of the supporting evidence—not the probability that the event will occur or that the stock will rise. Rumor Mill is separate from the WSS score.
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial